MEDIA

Latest News

Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences.

05 May 2023

Is Daxxify Going to Disrupt the Injectables Industry?

21 April 2023

Daxxify vs. Other Neurotoxins: How the New Wrinkle-Relaxer Stacks Up

16 March 2023

5 Reasons Daxxify Is the Most Unique Neurotoxin

10 March 2023

What Is Daxxify? Everything You Need to Know About the New Botox Alternative

08 March 2023

Everything you need to know about DAXXIFY®

28 February 2023

This FitFace Facial Sculpting Approach Features Daxxify At Its Core

10 February 2023

Often Lasting Twice as Long as Any Other Neurotoxin on the Market, Daxxify Makes Its US Debut

20 December 2022

What You Should Know About Daxxify, the New Botox Alternative

21 October 2022

Aesthetics Company Appoints Chief Medical Officer

19 October 2022

A Growing Neuromodulator Market: Daxxify Approved

18 October 2022

Daxxify Is The New Injectable You’re Going To See Everywhere in 2023

26 September 2022

Two New Studies Highlight the Efficacy and Safety Profile of Revance’s DAXXIFY